| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |